In nearly every survey of physician sentiment, doctors cite administrative burdens associated with payer relations as distracting from patient care and the performance of their chosen profession.
They weren’t looking for it, but researchers at the University of California, Los Angeles, say they have uncovered a promising hair-loss treatment, the online New York Times reports.
Risks of developing melanoma and prostate cancer are increased among those with a diagnosis of male factor infertility.
Herbal supplements and other complementary therapies are surrounded by clinical and ethical issues, some involving urologists.
PSA is falsely lowered by a factor of two in middle-aged men who have taken the hair-loss drug finasteride (Propecia) for 1 year, according to a study published in Lancet Oncology online.
Atlanta—Neoadjuvant chemotherapy using a three-drug combination has demonstrated activity in locally advanced transitional cell carcinoma (TCC) of the bladder, but it also possesses considerable toxicity. That was the conclusion reported in a poster by University of Michigan researchers at the American Society of Clinical Oncology annual meeting.
Atlanta—Are nanobacteria involved in prostate disease? That question hasn't been settled, but evidence of these controversial organisms has been found in the prostates and serum of men with prostatic inflammation.
Paris—Administration of corticosteroid therapy does not significantly increase the expulsion rate of distal ureteral stones. However, the synergistic effect of steroid therapy with concomitant administration of the alpha-blocker tamsulosin (Flomax) increases the effectiveness of tamsulosin, Italian researchers reported at the recent European Association of Urology annual congress here.